Company / Net Income
Protagonist Therapeutics, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$130.1M
FY2025
5-year range
-$130.1M / $275.2M
FY2021-FY2025
Trend
-147.3%
vs FY2024
Sector context
#120 of 216
Health Care
What the data says
At -$130M, Protagonist Therapeutics, Inc.'s net income ranks #120 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$130M in FY2025 to $275M in FY2024.
Based on SEC 10-K filings.
-$130M in FY2025.
Declined from -$79M to -$130M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 216 in Health CareTop 56% of 216This company -$130.1M Sector average $454.3M
▼
-128.6% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 147.3% year-over-year.
- Ranks #120 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$130.1M | -147.3% |
| FY2024 | $275.2M | +448.5% |
| FY2023 | -$79.0M | +38.0% |
| FY2022 | -$127.4M | -1.5% |
| FY2021 | -$125.6M | -89.8% |
| FY2020 | -$66.2M | +14.3% |
| FY2019 | -$77.2M | -98.3% |
| FY2018 | -$38.9M | -5.3% |
| FY2017 | -$37.0M | +0.6% |
| FY2016 | -$37.2M | -150.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026